Literature DB >> 1627381

Stability of K-ras mutations throughout the natural history of human colorectal cancer.

L Losi1, J Benhattar, J Costa.   

Abstract

We have used a rapid, non-radioactive and sensitive method based on allele-specific amplification using the polymerase chain reaction for the identification of K-ras mutations in archival tissues of colorectal carcinomas. Our purpose was to determine whether or not K-ras mutation provides, when present, a tumour marker throughout the natural history of the disease. We have studied 35 patients who developed recurrent cancer. In 71% of these patients a ras mutation in codons 12 or 13 was observed in the primary tumour. For each of these cases an identical ras mutation was found in the DNA from the local or distant recurrence. In the 29% of cases where no ras mutation was observed in the primary tumour, no newly acquired ras mutation appeared in the recurrent tumour. The time interval between primary tumours and recurrences varied from 3 to 60 months. Our results indicate that K-ras mutation provides a stable tumour marker throughout the natural history of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627381     DOI: 10.1016/0959-8049(92)90468-h

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  19 in total

1.  Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.

Authors:  Maria Arcila; Christopher Lau; Khedoudja Nafa; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

Review 2.  Pragmatic issues in biomarker evaluation for targeted therapies in cancer.

Authors:  Armand de Gramont; Sarah Watson; Lee M Ellis; Jordi Rodón; Josep Tabernero; Aimery de Gramont; Stanley R Hamilton
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

3.  Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.

Authors:  Robert P Whitehead; Sheryl McCoy; John S Macdonald; Saul E Rivkin; Marcus A Neubauer; Shaker R Dakhil; Heinz-Josef Lenz; Michael S Tanaka; James L Abbruzzese
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

4.  A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.

Authors:  B M Ryan; F Lefort; R McManus; J Daly; P W N Keeling; D G Weir; D Kelleher
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 5.  Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.

Authors:  Jara M Baas; Lisanne L Krens; Henk-Jan Guchelaar; Hans Morreau; Hans Gelderblom
Journal:  Oncologist       Date:  2011-07-08

6.  Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?

Authors:  M A Allard; R Saffroy; P Bouvet de la Maisonneuve; L Ricca; N Bosselut; J Hamelin; E Lecorche; M A Bejarano; P Innominato; M Sebagh; R Adam; J F Morère; A Lemoine
Journal:  Target Oncol       Date:  2014-11-26       Impact factor: 4.493

7.  Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples.

Authors:  R Ward; N Hawkins; R O'Grady; C Sheehan; T O'Connor; H Impey; N Roberts; C Fuery; A Todd
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

Authors:  P Chaubert; J Benhattar; E Saraga; J Costa
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

9.  Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas.

Authors:  P Zauber; M Sabbath-Solitare; S P Marotta; D T Bishop
Journal:  Mol Pathol       Date:  2003-06

10.  KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer.

Authors:  Garrett M Nash; Mark Gimbel; Alfred M Cohen; Zhao-Shi Zeng; Mackevin I Ndubuisi; Daniel R Nathanson; Jurg Ott; Francis Barany; Philip B Paty
Journal:  Ann Surg Oncol       Date:  2009-10-08       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.